LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017

LumiThera® Inc., a clinical stage medical device company focused on delivering non-invasive photobiomodulation (PBM) therapies for ocular disorders and disease, today announced it has been awarded the prestigious “MOST INNOVATIVE AND PROMISING MEDTECH & E-HEALTH COMPANY” during Biovision 2017 in Lyon, France.

This is great news for patients suffering from dry AMD who have no other treatment alternatives!

Read the full press release:
LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017

Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I think it will be the first billion dollar photobiomodulation company.